AccuStem Sciences, Inc.
ACUT
$0.388
$0.11240.58%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -45.08% | -17.49% | 21.34% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.26% | -15.95% | 24.60% | -- | -- |
| Operating Income | 45.26% | 15.95% | -24.60% | -- | -- |
| Income Before Tax | 45.26% | 15.95% | -24.60% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.26% | 15.95% | -24.60% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.26% | 15.95% | -24.60% | -- | -- |
| EBIT | 45.26% | 15.95% | -24.60% | -- | -- |
| EBITDA | 45.32% | -0.50% | -64.94% | -- | -- |
| EPS Basic | 46.76% | 20.29% | -15.86% | -- | -- |
| Normalized Basic EPS | 46.75% | 20.28% | -15.89% | -- | -- |
| EPS Diluted | 46.76% | 20.29% | -15.86% | -- | -- |
| Normalized Diluted EPS | 46.75% | 20.28% | -15.89% | -- | -- |
| Average Basic Shares Outstanding | 3.02% | 6.29% | 9.71% | -- | -- |
| Average Diluted Shares Outstanding | 3.02% | 6.29% | 9.71% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
